SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Ohr Pharmaceutical Inc. shuts sustained release tech lab

23-Feb-2017 - Ohr Pharmaceutical Inc. has halted activities at the laboratory in San Diego, California where research on its sustained release delivery technology was carried out.

Modus raises cash for Ph II trial of Sickle Cell drug in EU, Middle East and Caribbean

22-Feb-2017 - Modus Therapeutics AB has raised an additional 32m SEK (£2.85m) for its Phase II trial for pain crises in Sickle Cell Disease, running in the Caribbean, Middle East and Europe.

Tilray grows capacity in North America's only GMP cannabis facility

16-Feb-2017 - Medical cannabis supplier Tilray has expanded its formulary team and mooted the idea of extending its distribution network just weeks after the EMA granted its Canadian production site GMP accreditation.

Workers strike at Merck injectable drug plant in Goa, India over wages

09-Feb-2017 - Workers at a Merck KGaA injectable drug and soft gel capsules plant in Goa, India have gone on strike over a wages dispute.

Rentschler: Stabilisation tech sparks 'paradigm shift' for bio-formulation services

02-Feb-2017 - Rentschler Biotechnologie has added an antibody stabilising platform to its manufacturing services through a strategic alliance with formulation tech firm Leukocare.

Ferring licenses Enteris Peptelligence to turn injectable into oral drug

30-Jan-2017 - Ferring is the third company in a week which will use Enteris BioPharma’s Peptelligence engineering platform for small molecules to develop oral formulations.

Beximco forms manufacturing JV with Malaysia's BioCare

30-Jan-2017 - Beximco Pharmaceuticals Limited has partnered with BioCare Manufacturing Sdn Bhd to make generic drugs for the Malaysian market.

Lundbeck banks on shark antibody delivery tech to cross blood-brain barrier

27-Jan-2017 - Shark antibodies are an attractive way to deliver biologics to the brain, says Ossianix which is using its blood-brain barrier (BBB) crossing technology in collaboration with Lundbeck.

Enteris to work on Sanofi oral type 2 diabetes candidate & metabolic peptide for Nordic Bioscience

Sanofi and Nordic Bioscience deals ‘validate’ oral delivery tech, Enteris

25-Jan-2017 - Enteris Biopharma has secured two deals in as many days to use its excipient-based platform to enhance delivery of preclinical peptide candidates.

Belgian CDMO to launch generic of vaginal contraceptive device NuvaRing

24-Jan-2017 - Mithra Pharmaceuticals SA will seek US and EU approval for a rival to the NuvaRing contraceptive device in Q2, manufacturing the ring through its independent CDMO platform.

Ocular Therapeutix has resubmitted Dextenza to US FDA after CRL

23-Jan-2017 - Ocular Therapeutix Inc. has resubmitted its eye pain drug Dextenza to the US FDA claiming it has solved manufacturing problems that saw the agency reject the drug in July.

News in brief

Cipla targets South African asthma market with breath activated inhaler

19-Jan-2017 - Cipla has launched a breath activated inhaler in South Africa.

MannKind ‘aggressively’ moving forward with inhalable epinephrine

16-Jan-2017 - MannKind Corporation met with the US FDA last month to discuss a single-use disposable epinephrine inhaler it says could be an affordable alternative to the Epipen.

Catalent to assess resveratrol formulation across softgel platforms

11-Jan-2017 - Catalent will assess Jupiter Orphan Therapeutics’ resveratrol across its softgel technologies in an effort to improve the bioavailability of the rare disease candidate.

Proveca hires Quotient unit to develop more kid-friendly formulations

10-Jan-2017 - Quotient Clinical has been hired to develop child-friendly formulations of several off-patent drugs by Proveca Ltd.

Aurobindo to add Portuguese capsule and tablet capacity through Generis Farmaceutica buy

09-Jan-2017 - Aurobindo Pharma Limited has agreed to buy Portugal-based Generis Farmaceutica SA for €135m in a deal that includes a tablet and capsule plant in Amadora.

Shire offloads mRNA tech and staff to RaNa Therapeutics

05-Jan-2017 - Shire has sold its MRT messenger RNA platform to RaNA Therapeutics but will retain an equity stake in the Cambridge, Massachusetts-based biotech.

Intarcia receives $140m Gates Foundation grant for needle-free HIV tech

04-Jan-2017 - The Gates Foundation has invested $140m in Intarcia Therapeutics Inc to develop the biotech’s needle-free delivery pump for use with an HIV prophylactic therapy.

Prokarium and Probiomed team to scale-up thermostable oral vaccine

04-Jan-2017 - The project funded by the UK and Mexican governments will look to prove the scalability of Prokarium’s oral vaccine platform, the firm says.

AstraZeneca opens UK Zoladex plant

21-Dec-2016 - AstraZeneca has opened a £120m ($148m) cancer treatment manufacturing site in Macclesfield in the UK.

News in brief

Claris to sell injectable drug business and facilities to Baxter

19-Dec-2016 - Baxter International has agreed to pay Claris Lifesciences $625m (€598m) for three manufacturing facilities and a portfolio of 11 approved injectable drugs.

Lonza to buy Capsugel for $5.5bn, no site divestitures planned

15-Dec-2016 - Lonza has agreed to buy US capsule manufacturer Capsugel for $5.5bn (€5.2bn) in cash in an acquisition the Swiss firm says will expand its drug delivery business and enable savings of CHF100m a year by 2019.

US FDA slams delivery patch firm Pocono Coated Products over sub-potent meds

14-Dec-2016 - The US FDA has criticized Pocono Coated Products' (PCP) efforts to bring its transdermal patch plant in Cherryville, North Carolina into compliance with cGMP standards.

Lonza confirms interest in Capsugel takeover

12-Dec-2016 - Lonza has confirmed it is interested in buying Capsugel. 

Growth in biologics and vaccines leading injectables business, Aptar Pharma

12-Dec-2016 - Aptar Pharma is nearing completion of its US-based manufacturing site, as it continues to expand globally to keep pace with growth in the injectable drug delivery industry.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...

Products

Producing the perfect soft gel
Leading manufacturer of gelatine and collagen peptides